boldenone has been researched along with fulvestrant in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kunselman, AR; Legro, RS; Miller, SA; Satyaswaroop, PG | 1 |
Allen, JD; Arnold, JT; Blackman, MR; Le, H; Liu, X; McFann, KK | 1 |
2 other study(ies) available for boldenone and fulvestrant
Article | Year |
---|---|
Role of androgens in the growth of endometrial carcinoma: an in vivo animal model.
Topics: Androgens; Animals; Aromatase; Blotting, Western; Carcinoma; Disease Models, Animal; Electrophoresis, Agar Gel; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Regression Analysis; Testosterone; Transplantation, Heterologous | 2001 |
Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Cell Division; Cell Line, Tumor; Dehydroepiandrosterone; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Fulvestrant; Gene Expression; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; RNA, Small Interfering; Testosterone; Tosyl Compounds | 2007 |